Medicare Enrolled

Dr. Larisa Lehmer, MD

Dermatology · Newport Beach, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1441 AVOCADO AVE, Newport Beach, CA 92660
4970678869
In practice since 2016 (10 years)
NPI: 1760845929 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lehmer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lehmer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lehmer

Dr. Larisa Lehmer is a dermatology specialist in Newport Beach, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Lehmer performed 4,178 Medicare services across 1,381 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lehmer received a total of $2,170 from 22 pharmaceutical and/or device companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lehmer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 30% volume in CA $2,170 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,178
Medicare services
Top 30% in CA for dermatology
1,381
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~418 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Photodynamic therapy gel for precancerous skin 1,604 $1 $13
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
603 $6 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
354 $100 $267
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
271 $75 $225
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
233 $45 $111
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
228 $38 $146
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
176 $74 $189
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks 113 $371 $1,200
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
109 $93 $249
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
98 $1 $29
Skin growth removal and lab exam, 1-5 blocks
This procedure involves the removal of a growth from the head, neck, hands, feet, or genitals. The removed tissue is then examined under a microscope in the laboratory.
87 $580 $2,250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
55 $132 $345
Injection into skin growths, 1-7
A procedure involving the injection of medication into one to seven skin growths.
37 $44 $123
Additional Mohs surgery stage with microscopic exam
This procedure involves the removal and microscopic examination of an additional stage of tissue from the trunk, arms, or legs. It is performed in stages to ensure complete removal of the growth.
36 $352 $1,200
Skin growth removal and lab exam, 1-5 blocks
A procedure to remove a growth from the trunk, arms, or legs and send 1 to 5 tissue samples to a laboratory for microscopic examination.
29 $511 $2,250
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
26 $110 $528
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
24 $152 $366
Complicated wound repair of trunk, 2.6-7.5 cm
A surgical procedure to close a complex wound on the trunk that measures between 2.6 and 7.5 centimeters in length.
21 $300 $867
Destruction of cancer skin growth, 1.1-2.0 cm
Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters.
18 $101 $386
Light application with debridement to destroy precancerous skin growth
This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths.
16 $261 $975
Shaving of skin growth, 0.6-1.0 cm
A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters.
14 $75 $269
Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm
A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length.
13 $353 $924
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $89 $233
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
15.3% medium
83.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,170
Total received (2020-2024)
Avg $434/year across 5 years
Top 45% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
85
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,170 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$879
2023
$600
2022
$305
2021
$270
2020
$116

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$198
Dermavant Sciences, Inc.
$132
Galderma Laboratories, L.P.
$119
GENZYME CORPORATION
$118
Amgen Inc.
$64
Regeneron Healthcare Solutions, Inc.
$55
Arcutis Biotherapeutics, Inc.
$43
Novartis Pharmaceuticals Corporation
$40
ABBVIE INC.
$35
REVANCE THERAPEUTICS, INC.
$26
Lilly USA, LLC
$20
LEO Pharma Inc.
$16
Biofrontera Inc.
$14
Top 3 companies account for 51.0% of 2024 payments
All-time payments by company (2020-2024) ›
PFIZER INC.
$332
Galderma Laboratories, L.P.
$262
Regeneron Healthcare Solutions, Inc.
$213
GENZYME CORPORATION
$206
Amgen Inc.
$198
Novartis Pharmaceuticals Corporation
$151
Dermavant Sciences, Inc.
$151
Sun Pharmaceutical Industries Inc.
$126
Incyte Corporation
$106
Arcutis Biotherapeutics, Inc.
$88
Biofrontera Inc.
$70
Lilly USA, LLC
$36
Janssen Biotech, Inc.
$36
ABBVIE INC.
$35
REVANCE THERAPEUTICS, INC.
$26
MAYNE PHARMA INC.
$24
Almirall LLC
$22
DERMIRA, INC.
$21
STRATA Skin Sciences, Inc.
$20
Allergan, Inc.
$16
LEO Pharma Inc.
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Top 3 companies account for 37.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · Absorica LD · BLU-U · COSENTYX · DAXXIFY · DORYX · DUPIXENT · EUCRISA · LEVULAN KERASTICK · LITFULO · OPZELURA · ORACEA · Otezla · QBREXZA · SKYRIZI · Seysara · TALTZ · TREMFYA · VTAMA · Winlevi · XTRAC · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in Newport Beach?
Compare dermatologists in the Newport Beach area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
257
Per 100K population
8.1
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lehmer is a mixed practice specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lehmer experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Lehmer performed 1,604 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lehmer receive payments from pharmaceutical companies?
Yes. Dr. Lehmer received a total of $2,170 from 22 companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lehmer's costs compare to other dermatologists in Newport Beach?
Dr. Lehmer's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lehmer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →